VitroScan
Leiden, Netherlands
VitroScan operates an ex vivo drug response platform designed for cancer treatment. By cultivating patient-derived micro-tumors in a 3D matrix, the company predicts clinical responses to therapeutics. They serve biopharma clients to de-risk drug development and accelerate translation through near-clinical testing. Simultaneously, they offer clinical trial programs for patients and doctors to individualize treatment strategies, improving efficacy and reducing adverse events. Operating under ISO-15189 standards, VitroScan integrates precision patient testing with drug development to advance functional precision oncology beyond molecular profiling.
Only accessible to MedStartr community members.
Join nowCompany Info
- Website
- vitroscan.nl
Only accessible to MedStartr community members.
Join nowWhat do you think of VitroScan?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now